Inspection Record

Sun Pharmaceutical Industries Limited — Health Canada Inspection Findings

Health CanadaInspected 2023-06-26 3 findingsMaterial and supplier controlComputer system validationEquipment and facility

View the regulator's official source The source document is always the basis for judgement.

Findings

1Material and supplier control

The handling and/or storage of samples was inadequate for raw materials, drugs being processed, bulk drugs, and/or finished products.

2Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

3Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2023-06-26. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

2025-12-31 · EMA (Europe) · 1 findings2025-06-13 · US FDA · 8 findings2024-11-18 · Health Canada · 12 findings2024-05-06 · Health Canada · 9 findings2023-12-15 · US FDA · 6 findings2024-03-11 · Health Canada · 4 findings
Sun Pharmaceutical Industries Limited findings history — including this company's other documents Health Canada documents, 2023 Go to Findings search